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CO-CULTURES of porcine articular cartilage and
synovium or synovial conditioned medium were
used as an in vitro model to mimic inflammatory
events at the cartilage/synovial junction in degen-
erative joint disease. This model provides a useful
tool to assess the anti-inflammatory and anti-
arthritic properties of pharmacological agents. In
this study the effects of copper and zinc on (i) PG
synthesis by cartilage and (ii) synovial-induced
PG depletion have been investigated. Copper
sulphate at a concentration of 0.01raM did not
stimulate PG synthesis significantly in cultured
cartilage explants but completely abrogated the
inhibRory effects of synovial tissue in co-culture
experiments. This finding was supported by the
histological demonstration of copper-dependent
reversal of the PG depletion in cartilage exposed
to synovial conditioned medium. Zinc sulphate at
0.01mM had no effect on PG synthesis and was
unable to protect cartilage against synovial-
induced PG depletion. These results reveal
possible mechanisms by which copper exerts its
anti-inflammatory and anti-arthritic actions.
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Introduction
Copper and zinc are essential trace minerals
known to have important roles in immune
-
and inflammatory-6 processes. Adequate
amounts of both minerals are required for
normal maturation and function of the immune
system, and deficiency, particularly of zinc,
results in diminished immune responsiveness
due to inhibition of T cell-mediated cytotoxicityr
and antibody production. It is also well estab-
lished that dietary deficiency of copper and zinc
correlates with enhanced acute inflammatory
responses.6,9,1
Although the therapeutic anti-inflammatory
properties of copper and zinc have been exten-
sively studied, both in human disease and in
animal models,1- surprisingly little is known
about their mechanisms of action. Even less infor-
mation is available concerning their anti-arthritic
action.14-16 In order to gain some insight into
anti-arthritic mechanisms we used a co-culture
model of cartilage and synovial tissue to mimic
events occurring at the cartilage/synovial pannus
junction, the site of the initial pathological
process of rheumatoid joint disease. As a result of
an inflammatory reaction the synovial membrane
becomes infiltrated by immunocompetent cells to
form the pannus which invades the cartilage
surface and underlying bone. Concomitant trig-
gering of the cytokine network and production of
degradative enzymes leads to depletion of the
extracellular matrix macromolecules proteoglycan
and collagen, and eventually to joint destruction.
Our in vitro co-culture model provides a useful
tool for studying the mechanism of action of
pharmacological agents on the cellular and media-
tor interactions which play a role in these destruc-
tive pathological processes.
The aim of the present study was to investigate
the ability of copper and zinc to abrogate the
degradative effects of synovial tissue on cartilage
matrix proteoglycan.
Materials and Methods
Tissue samples.. Macroscopically normal articular
cartilage was obtained from the condylar ridge of
metacarpo-phalangeal joints of pigs aged 6-9
months obtained from the local abattoir. Carti-
lage samples were collected into sterile Dulbec-
co’s Modified Eagle’s Medium (DMEM; Gibco)
for subsequent culture experiments. Synovial villi
and attached subsynovial tissue were dissected
from the joint capsule lining of several meta-
carpo-phalangeal joints. The tissue was pooled
and minced in preparation for co-culture as
171Sdescribed previously.
Culture conditions: Cultures were carded out
under sterile conditions in serum-free DMEM,
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containing 0.58 mg/ml glutamine, 120 l.tg/ml
benzyl penicillin, 200 l.tg/ml streptomycin, in a
5% CO2 environment at 37C. In the first experi-
ment cartilage explants were cultured for 48 h in
the presence or absence of a range of concentra-
tions (0.01-2.0mM) of copper sulphate or zinc
sulphate in order to assess their effects on pro-
teoglycan (PG) synthesis. From these data non-
toxic concentrations were selected for further
experiments in which cartilage explants were co-
cultured in direct contact with minced synovium
in the presence or absence of copper and zinc
prior to measurement of PG synthesis.
In another group of experiments synovial
tissue was pre-cultured for 48 h in the presence
or absence of a range of copper sulphate con-
centrations (0.001-0.1 mM). The tissue-free syno-
vial conditioned medium was then cultured with
cartilage explants for a further 48h, at which
time the explants were removed, snap-frozen in
OCT embedding medium (Miles Diagnostics) in
liquid nitrogen and stored at-70C prior to sec-
tioning for toluidine blue histology. Five cartilage
explants were used for each experimental group.
Measurement of proteoglycan (PG) synthesis:
After culture in the presence of copper and zinc,
or co-culture with synovial tissue, the explants
were radiolabelled essentially as described pre-
viously9 by placing fresh DMEM containing 20
l.tCi/ml (0.74 MBq/ml) of [5S]-sulphate and
incubating for 2h at 37C. The explants were
then digested in papain (300 l.tg/ml) for 2h at
65C and the PG synthesis rate determined as
the 35SO42- incorporation, and expressed as
CPM/mg dry weight of cartilage.
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FIG. 1. Proteoglycan synthesis, expressed as CPM 35S04 uptake
in articular cartilage cultured for 48 h alone and in the presence
of increasing concentrations of copper sulphate (A) or zinc sul-
phate (B). (Means -t- S.E.M. (n 5); *p < 0.05; ***p < 0.001.)
Toluidine blue histology: Frozen sections 5-8 l.tm
thick were cryostat cut at-25-35C from carti-
lage explants exposed to synovial conditioned
medium. The sections were placed on poly--
lysine (Sigma) 8-well multitest slides (Flow Labs)
and stained with toluidine blue for visual assess-
ment of proteoglycan depletion.
Statistics: Proteoglycan synthesis measurements
were performed in quintuplicate in every experi-
ment. The dose-response experiments of copper
and zinc on proteoglycan synthesis were done
twice. The co-culture experiments were done
three times with copper and twice with zinc, and
the synovial conditioned medium experiment
was done only once. Statistical evaluation of the
data was done using Student’s t-test.
Results
Effects of copper and zinc on PG synthesis by
cartilage explants: In two separate experiments
copper sulphate at concentrations of 0.1 mM and
below had little effect on PG synthesis in 48h
cartilage cultures. Since there was wide variation
in basal PG synthesis between the two experi-
ments the results were not combined. The
results from a typical experiment are shown in
Fig. I(A). Higher concentrations of copper (0.25-
2.0mM) caused a dose-dependent decrease in
PG synthesis.
Zinc sulphate at 0.01 mM caused a slight but
non-significant increase in PG synthesis
(Fig. I(B)). Concentrations of zinc above
0.01 mM caused a dramatic and complete inhibi-
tion of PG synthesis.
From these results we selected a concentration
of 0.01 mM for both copper and zinc sulphate in
the co-culture experiments. Previous determina-
tion of toxic levels for cartilage and isolated
chondrocytes2 confirm that 0.01mM is non-
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A cartilage.. Toluidine blue staining of sulphated
-]- PG in cartilage sections allows good qualitative
assessment of PG content in the extracellular
matrix.17 Figure 3 illustrates typical staining pat-
terns seen in frozen sections prepared from the
explants from the five different experimental
groups. Figure 3(A) shows uniform metachro-
matic staining throughout the matrix, with slight
depletion at the tip, in cartilage cultured alone
for 48h. Cartilage cultured in synovial condi-
tioned medium shows characteristic extensive
loss of metachromasia (Fig. 3(B)). Pre-treatment
of synovium with 0.001 mM copper sulphate had
c a ft. ca rt. c ft. + syn little effect on the depletion of metachromasia
alone + syn + 0.01 mM (Fig. 3(C)) but higher concentrations increased
copoe sulpoe the intensity of staining (0.01mM, Fig. 3(D)) indi-
cating markedly reduced loss of metachromasia
induced by the copper-pretreatment conditioned
B medium (0.1 mM, Fig. 3(E)).
Discussion
cart.
alone
cart. cart. + syn
+ syn + 0.01rnM
zinc sulphate
Experimental studies show that copper and
zinc are involved in the expression and control
of inflammation. How their metabolism changes
in inflammation and how they can affect the
development of inflammatory processes is
unknown. In an attempt to gain insight into their
possible anti-inflammatory and anti-arthritic
mechanisms, we have investigated the effects of
copper and zinc in an in vitro model of rheuma-
toid joint inflammation.
Our results presented here show that, co-
culture of articular cartilage in direct contact with
FIG. 2. Proteoglycan synthesis expressed as CPM 35804 uptake synovium, drastically reduced PG synthesis by
in articular cartilage cultured for 48 h alone (F-I}; co-cultured with
synovium alone ([])co-cultured with synovium in the presence chondrocytes (40%). When copper (0.01 mM)
of 0.01 mM copper sulphate (,) or 0.01 mM zinc sulphate (,). was added to the co-culture, the 35804 incor-
(Means 4- S.E.M. (n 5); **p < 0.01.) poration into the glycosaminoglycans indicated a
significant recovery of PG synthesis to reach the
toxic and well within the range of concentrations control values. On the contrary, zinc at the same
used in other studies.3’21’22 concentration (0.01mM)was unable to protect
cartilage against synovial-induced PG depletion.
Effects of copper and zinc on PG synthesis by The same inhibitory effect on PG synthesis has
cartilage co-cultured with synovium.. Co-culture also been found by pre-culturing the synovium
of cartilage with synovial tissue for 48h resulted for 2 days alone and then adding the synovial
in marked reduction in PG synthesis. Figure2(A) conditioned medium (SCM) to the cartilage
shows the results of a typical experiment in explants for 2 more days. In fact, cartilage cul-
which synovial tissue caused a 40% reduction in tured in SCM alone showed a pronounced loss
PG synthesis by cartilage. The presence of of toluidine blue staining, reflecting depletion of
copper sulphate at a concentration of 0.01 mM matrix PG. This extensive reduction of metachro-
during the 48h culture period abrogated the masia did not occur if the synovium had been
inhibitory effects of synovium (p < 0.01). pre-cultured in the presence of copper
Zinc sulphate at a concentration of 0.01 mM (0.01 mM) and if copper was still present in SCM
was unable to reverse the inhibitory effects of added to cartilage, demonstrating a copper-
synovial tissue on PG synthesis (Fig. 2(B)). dependent reversal of PG depletion in cartilage
exposed to SCM.
Effect of conditioned medium from copper- From these results we can conclude that (i)
treated synovium on PG content in cultured the PG-degrading effect of synovium on cartilage
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FIG. 3. Toluidine blue staining in frozen sections of articular cartilage cultured for 48 h alone (A), with 48h synovial conditioned
medium (B) or with conditioned medium from synovium pre-treated for 48 h in the presence of 0.001 mM (C), 0.01 mM (D) or 0.1 mM
(E) copper sulphate.
does not necessarily require direct synovium-car-
tilage contact, but is likely attributable to media-
tors released from the synovium into the
medium; (ii) copper is protective on cartilage
matrix depletion either in co-culture or if the
two tissues are not simultaneously present in the
culture; and (iii) zinc is unable to reverse the PG
depletion by synovium.
Because copper was always present in the
medium, these results cannot distinguish
between an inhibitory effect of copper on syno-
vium or a stimulatory effect on PG synthesis in
cartilage. However, we have also shown that
copper added to the medium at a concentration
of 0.01 mM did not increase PG synthesis in carti-
lage cultured alone, supporting indirectly an
action of copper via synovium inhibition.
The original studies of Fell and Jubb17 in 1977
demonstrated the ability of porcine synovial
tissue to promote loss of PG from cartilage, and
it is now known that interleukin 1 (IL-1) is one
of the synovial mediators responsible for this
23 24degradative activity. Interestingly, recent
reports have shown that cotlPer is able to inhibitIL-1 activity25 and secretion," findings which may
explain our observations that copper protects
cartilage from synovium-induced destruction. At
present we have no direct evidence that copper
inhibits IL-1 in our co-culture system.
An alternative mechanism by which copper
may exert its protective action is via inhibition of
the free radical, nitric oxide (NO). Increasing evi-
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dence implicates NO in the pathophysiology of
arthritis,26 suggesting a role for NO in both the
inflammation and the chondrodepletion that
occurs in this disease. Recent data obtained by
Taskiran and co-workers27 demonstrate that
endogenously synthesized NO acts as the media-
tor of IL-l-dependent PG synthesis suppression.
Analyses of human synovial fluids s.uegest that
NO is synthesized locally within joints and that
synoviocytes can potentially serve as a source of
intra-articular NO.29
In support of this we have preliminary data
showing NO production by normal pig synovium
(data not shown), and furthermore we have
found a 50% reduction of NO content in SCM
when synovium was cultured in the presence of
non-toxic concentrations of copper (0.001-0.01
mM). The same SCM also abrogated the degrada-
tive effects of synovial tissue on cartilage, sug-
gesting a connection between copper, NO
reduction and cartilage protection. In the light of
these results and because Scuderi21 has recently
shown that copper may play an important role in
the homeostasis of cTtokines such as IL-1,2 we
could hypothesize an action of copper on PG
metabolism as indicated in Fig. 4.
The question as to whether copper affects NO
production directly or via modulation of IL-1
synthesis and/or secretion is under investigation.
In conclusion copper, in contrast to zinc, seems
to be able to protect cartilage from the destruc-
tive effects of mediators released by synovium.
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FIG. 4. A possible mechanism of action of copper on PG meta-
bolism.
Because loss of articular cartilage is the major
pathological lesion common to all arthritides,
copper chondroprotection may explain the thera-
peutic efficacy of this metal in maintaining carti-
lage integrity during the inflammation process.
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